Enquire Now

User icon

Phone icon

Email icon

WhatsApp Us
+91 886 141 4344
Chat with Us
cart Shop order Order now
hospital_bg
Pharma & Biotech

AI-Driven Drug Development for Better Disease Prevention

Genix.ai brings together AI in pharmacy and AI in genomics to support faster, more reliable decisions across research and development. Built for modern pharma and biotech teams, the platform connects genomic data, biomarker analysis, and clinical evidence to strengthen artificial intelligence in drug discovery and development, from early target identification to trial readiness.

Clinical genomics platform visualization

The Challenge in Pharma, Biotech and Genomic Drug Research

Pharma and biotech organisations generate large volumes of genomic, clinical, and multi-omic data, but turning that data into action remains a major challenge. Fragmented systems, slow interpretation, and limited translational visibility often delay progress in artificial intelligence drug discovery, AI in clinical research, and AI drug development.

Genomics workflows
Bioinformatics expertise
Interpretation times
Genomics workflows
Bioinformatics expertise

Disconnected genomics, clinical, and omics datasets

Limited precision in patient and cohort stratification

Manual biomarker discovery and validation workflows

Low transparency in analytical and AI-assisted outputs

Delays in moving insights into development decisions

How Genix.ai Supports AI in Pharmacy and Biotech Teams

Genix.ai delivers a genomics-led platform for artificial intelligence in pharmacy and the pharmaceutical industry. It helps research teams turn genomic evidence into structured, explainable outputs that support biomarker discovery, translational science, and clinical development.

Analyse genomic data
with population and disease relevance

Strengthen biomarker discovery
and validation with AI-assisted workflows

Support explainable decisions
across R&D, clinical research, and diagnostics

Accelerate AI in clinical trials
with smarter cohort selection

Support decision-making across R&D Clinic

AI-powered faster discovery

Your genes have answers. Are you ready?

Key Pharma & Biotech Use Cases

Biomarker Discovery and Validation

Patient and Cohort Stratification

Translational Research

Clinical Development Support

use_cases1
use_cases2
use_cases3
use_cases4

How the Platform Fits into AI in Drug Development Workflows

Genix.ai offers a research and development-ready genomics intelligence platform that links discovery, translational science, and clinical application. Designed for pharma and biotech teams, it supports AI in drug discovery and genomic analysis to improve decision-making across the R&D lifecycle.

01

Data Integration

aaa1
02

Analytical Processing

aaa2
03

Interpretation & Review

aaa3
04

Insight Delivery

aaa4
Genix.ai’s Philosophy

BUILT FOR CONFIDENT GENOMIC DECISIONS

Genix.ai is designed for high-stakes genomic research where reproducibility matters. The platform supports artificial intelligence in clinical and genomic diagnostics through transparent workflows, version-controlled outputs, and clear separation between AI-assisted suggestions and expert-reviewed conclusions.

Capa_1

Transparent AI-assisted suggestions

Capa_1

Versioned workflows and annotations

Capa_1

Explainable evidence-backed outputs

Capa_1

Reproducible pipelines

Privacy-First Workflows for Regulated Research Environments

The platform supports secure collaboration for pharma, biotech, and research teams working with sensitive genomic and IP-heavy datasets. These are core applications of artificial intelligence in pharmaceutical industry settings where governance, access control, and deployment flexibility are critical.

hospital health

Secure collaboration across teams and partners

diagon lab

Controlled access to sensitive datasets

Pharma

Flexible deployment for regulated environments

Research

Alignment with data governance expectations

Safe and Secure
Public Health

compliance requirements

Privacy-First Workflows for Regulated Research

Genix.ai is built to support secure data handling across pharma, biotech, and genomic research environments. The platform enables controlled access, privacy-focused workflows, and smoother collaboration across teams working with clinical information, and research datasets.

SaaS

SaaS

Suitable for pilot programmes, exploratory research, and early evaluation.

On-Premise

On-Premise

Designed for highly regulated
environments and sensitive data
workloads.

Private VPC

Private VPC

A strong fit for long-term R&D programmes, proprietary datasets, and controlled enterprise deployment.

Why Pharma and Biotech Teams Choose Genix.ai

whylogopharma

Faster biomarker discovery and validation

whylogopharma

Stronger patient stratification for clinical programmes

whylogopharma

Explainable, audit-ready AI outputs

whylogopharma

Scalable from discovery research to clinical development

whylogopharma

Built for long-term scientific and operational use

Why hospitals choose genix.ai

Built for Teams Across Discovery, Genomics, and Clinical Development

whylogopharma

Translational medicine teams

whylogopharma

Biomarker and genomics scientists

whylogopharma

Clinical development leaders

whylogopharma

Data science and informatics teams

whylogopharma

Research collaborators and innovation partners

Why hospitals choose genix.ai

Start a Conversation

Share a few details to explore how Genix.ai can support AI in genomics, biomarker discovery, and artificial intelligence pharmaceutical industry workflows.

User icon
Organization icon
Phone icon

Frequently Ask Questions

1. How does artificial intelligence in drug discovery improve biomarker discovery?
Genix.ai combines genomic evidence and clinical signals to identify and prioritise biomarker candidates faster. This helps reduce manual review and supports more confident decisions in artificial intelligence drug discovery workflows.
2. How does AI in genomics support AI in clinical trials and AI in clinical research?
The platform helps stratify patients using genotype and phenotype patterns, making it easier to identify suitable cohorts, improve trial design, and support more precise research decisions across development programmes.
3. What is the use of AI in pharmaceutical industry settings for genomic diagnostics?
The use of AI in pharmaceutical industry environments includes genomic interpretation, biomarker validation, cohort selection, and evidence synthesis. Genix.ai also supports artificial intelligence in clinical and genomic diagnostics through explainable and review-ready workflows.
4. How does artificial intelligence in pharmacy support drug discovery and development?
Artificial intelligence in pharmacy supports target discovery, translational research, and data-led development planning. By connecting genomic analysis with structured evidence, Genix.ai strengthens artificial intelligence in drug discovery and development across the full R&D lifecycle.
5. What role does testing play in the platform’s pharma and biotech workflows?
Testing is central to the value Genix.ai delivers for pharma and biotech teams. The platform helps convert testing data into actionable research insights for biomarker discovery, patient stratification, target evaluation, and genomic diagnostics. By combining DNA-led evidence with genetic intelligence, Genix.ai strengthens artificial intelligence in clinical and genomic diagnostics and supports more precise research and development decisions.
6. How does Genix.ai address explainability in AI-driven research?
Genix.ai is designed for transparent and explainable analysis. Rather than producing black-box outputs, the platform supports evidence-backed interpretation with traceable reasoning layers, structured review, and reproducible workflows. This is especially important for organisations using AI-driven drug discovery, where scientific credibility, audit readiness, and expert validation remain essential. Explainability also strengthens confidence in the use of AI in pharmaceutical industry workflows involving genomic and clinical data.
7. What deployment models are available for sensitive research, IP, and clinical data?
Genix.ai offers flexible deployment models to support the needs of AI in the pharmaceutical industry landscape. Options can include SaaS for pilot programmes, Private VPC for dedicated cloud environments, and On-Premise deployment for highly sensitive or regulated data. This allows pharma and biotech organisations to adopt artificial intelligence in pharmacy and genomic intelligence tools while maintaining strong control over research data, clinical datasets, and intellectual property.
8. Is the platform ready for regulatory audits and GxP compliance?
Yes. Genix.ai features robust role-based access controls (RBAC), end-to-end data encryption, and comprehensive audit logs. Our security architecture is aligned with HIPAA, GDPR, and DPDP standards, ensuring readiness for clinical development and regulatory scrutiny.

Bring Clinical Genomics into Routine Hospital Care

If your hospital or health system is evaluating how to operationalize genomics responsibly and at scale, Genix.ai can support your journey.

Genix.ai - Genomic Precision Wellness
Genix.ai Logo

Genix.ai is an AI-powered clinical platform using NGS and imaging to detect biomarkers early, enabling clinicians to deliver cost-effective, personalized treatments for rare pediatric conditions, cancer care, and infectious diseases.

©2026 Radiome Health Private Limited.

Developed in Association with Chadura.